Cargando…

Phosphorylated Neurofilament Heavy Chain (pNFH) in Clinically Isolated Syndrome and Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	TÜZÜN, Erdem, ŞANLI, Elif, AKBAYIR, Ece, TÜRKOĞLU, Recai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Noro-Psikiyatri Arsivi 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665293/ https://www.ncbi.nlm.nih.gov/pubmed/34924782 http://dx.doi.org/10.29399/npa.28019

Ejemplares similares

Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis
por: Zecca, Chiara, et al.
Publicado: (2022)

Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis
por: Türkoğlu, Recai, et al.
Publicado: (2022)

Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behçet’s disease
por: KARAASLAN, Zerrin, et al.
Publicado: (2022)

Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Karaaslan, Zerrin, et al.
Publicado: (2023)

Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy
por: Badina, Mihaela, et al.
Publicado: (2023)

Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion
por: Olby, Natasha J., et al.
Publicado: (2019)

A Case of Seronegative Limbic Encephalitis with Multiple Sclerosis: A Possible Overlapping Syndrome
por: Karaaslan, Zerrin, et al.
Publicado: (2017)

Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments
por: Ackerley, Steven, et al.
Publicado: (2003)

NfL and pNfH are increased in Friedreich’s ataxia
por: Hayer, Stefanie Nicole, et al.
Publicado: (2020)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression
por: Türkoğlu, Recai, et al.
Publicado: (2014)

Phosphorylated Neurofilament Heavy Chain Correlations to Visual Function, Optical Coherence Tomography, and Treatment
por: Pasol, Joshua, et al.
Publicado: (2010)

Vasculocentric Axonal NfH in Small Vessel Disease
por: Anad, Adam, et al.
Publicado: (2022)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology()
por: Petzold, Axel, et al.
Publicado: (2008)

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
por: Ho, Samantha, et al.
Publicado: (2023)

Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)
por: Guy, John, et al.
Publicado: (2008)

Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits
Publicado: (1995)

A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain
por: Sisman, Aysel Büsra, et al.
Publicado: (2020)

Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2021)

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
por: Kušnierová, Pavlína, et al.
Publicado: (2019)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis
por: Voskuhl, Rhonda, et al.
Publicado: (2022)

Neurofilament-dependent Radial Growth of Motor Axons and Axonal Organization of Neurofilaments Does Not Require the Neurofilament Heavy Subunit (NF-H) or Its Phosphorylation
por: Rao, Mala V., et al.
Publicado: (1998)

Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes
por: Qiao, Xiaona, et al.
Publicado: (2015)

Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease
por: Falzone, Yuri Matteo, et al.
Publicado: (2020)

Serum phosphorylated neurofilament heavy chain as a diagnostic biomarker for progressive myelomalacia in dogs with thoracolumbar intervertebral disc herniation
por: Murthy, Vishal D., et al.
Publicado: (2021)

Production, partial optimization and characterization of keratinase enzyme by Arthrobacter sp. NFH5 isolated from soil samples
por: Barman, Nirmal Chandra, et al.
Publicado: (2017)

Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study
por: Li, Jin‐Yue, et al.
Publicado: (2023)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis
por: Kölliker Frers, Rodolfo A., et al.
Publicado: (2022)

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
por: Brune, Synne, et al.
Publicado: (2022)

Serum neurofilament heavy chains as early marker of motor neuron degeneration
por: De Schaepdryver, Maxim, et al.
Publicado: (2019)

Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
por: Thebault, Simon, et al.
Publicado: (2020)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
por: Joisten, Niklas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6urt6drl5e4126da50jm3flka